CEL-SCI Corporation CVM · Stock Open CEL-SCI Corporation in new tab
CEL-SCI Corporation Analysis (CVM)
Is CEL-SCI Corporation a good investment? CEL-SCI Corporation (CVM) is currently trading at 1.67 USD. Market analysts have a consensus price target of 12.50 USD. This suggests a potential upside from current levels.
Earnings Schedule: CEL-SCI Corporation is expected to release its next earnings report on Dec. 23, 2026. The market consensus estimate for Forward EPS is -6.38.
Investor FAQ
Does CEL-SCI Corporation pay a dividend?
No, it does not currently pay a dividend.
What asset class is CEL-SCI Corporation?
CEL-SCI Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Dec. 23, 2026. The company currently has a trailing EPS of -1.69.
Company Profile
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
| Year | Total Dividends |
|---|---|
| ▸1996 |
0.01 USD
|
| Aug. 28, 1996 | 0.0083 |
| Split Date | Split Ratio to 1 |
|---|---|
| May 1, 1995 | 1:10 |
| Sept. 25, 2013 | 1:10 |
| June 15, 2017 | 1:25 |
| May 20, 2025 | 0.03 |
Community Discussion